Cannabis Analysis and Testing News and Research

Latest Cannabis Analysis and Testing News and Research

Biosynthesis of cannabinoid precursor and other polyketides from amoebae

A research team at the Leibniz Institute for Natural Product Research and Infection Biology - Hans Knöll Institute in Jena, Germany has developed a new method to produce complex natural products in amoebae.

7 Mar 2022

Researchers discover a sustainable approach for drug development

Although several people think of medicines as purely synthetic compounds, nature is an important element of most of the medications humans depend on.

4 Feb 2022

New computational method could help quickly screen billions of drug compounds

Receptors are docking stations found on the surface of cells. Compounds such as caffeinE, dopamine, THC, and LSD, all bind to these receptors.

17 Dec 2021

Exposure to cannabis vapor reduces sperm counts and motility in two generations of mice

An intense but short-term exposure to cannabis vapor lowered sperm counts and slowed sperm movement, or motility, not only in the directly exposed male mice but also in their sons.

6 Dec 2021

A new standard for analytical testing in the cannabis industry

JEOL USA, Inc, a leader in the mass spectrometry space for over 60 years, will introduce their JMS-TQ4000GC triple quadrupole GC-MS/MS to the cannabis scientific community at MJBizCon, the preeminent Marijuana Business Conference for cannabis professionals, which takes place in Las Vegas from October 19th 2021 – October 22nd 2021.

From JEOL USA, Inc. 13 Oct 2021

Research finds an increase in prenatal cannabis usage

Kaiser Permanente analyzed more than 100,000 pregnancies and identified that there was a 25% increase in the rate of cannabis use early in pregnancy.

1 Oct 2021

Restek’s New Terpenes MegaMix Standards: 59 Compounds in Two Ampuls to Optimize Your Terpenes Analyses

Terpenes are aromatic compounds responsible for the characteristic aromas and flavors of most plants.

From Restek Corporation 1 Oct 2021

Recent cannabis use associated with myocardial infarction in young adults

Adults younger than 45 years who reported recently using cannabis were 2 times more likely to have had a heart attack (myocardial infarction), and this link was stronger in frequent users, according to new research in CMAJ.

From University of Toronto 9 Sep 2021

Researchers analyze the effects of using tetrahydrocannabinol during pregnancy

A group of scientists combined their mastery to obtain a thorough understanding of the risks linked with cannabis exposure at the time of pregnancy.

3 Sep 2021

Researchers discover new way to improve absorption and brain delivery of medicinal cannabis

A team of researchers led by Curtin University has discovered a new way to improve the absorption rate of medicinal cannabis when taken orally, which could potentially be used to treat neurological disorders such as Alzheimer’s disease, multiple sclerosis and traumatic brain injuries in the future.

21 Jun 2021

Novel peptide could allow cannabis to relieve pain while avoiding side effects

Many people live with chronic pain, and in some cases, cannabis can provide relief. But the drug also can significantly impact memory and other cognitive functions.

13 May 2021

Developing a portable tool to detect street drug ‘spice’

AZoLifeSciences speaks to researchers from the University of Bath about their latest research that led to the development of a device that can detect 'spice'.

From University of Bath 28 Apr 2021

Study sheds light on the ability of cannabidiol to reduce pain

It's been hailed as a wonder drug and it's certainly creating wonder profits. By some estimates, the Cannabidiol (or CBD) market could be worth $20 billion dollars by 2024. While users tout its effectiveness in pain relief, up until now there's been limited experimental human research on the actual effectiveness of the drug

26 Apr 2021

Synthetic cannabinoid reduces essential tremors by activating astrocytes

A research team from the Department of Neuroscience at the Faculty of Health and Medical Sciences has now made a recent finding that may prove crucial to upcoming studies and treatments using medical cannabis.

19 Mar 2021

Psychoactive component of marijuana stays in breast milk for up to six weeks, study finds

In a new study published in JAMA Pediatrics, researchers at Children's Hospital Colorado have found that tetrahydrocannabinol (THC), the psychoactive component of marijuana, stays in breast milk for up to six weeks, further supporting the recommendations of the American Academy of Pediatrics, the American College of Obstetricians and Gynecologists and the Academy of Breastfeeding Medicine to abstain from marijuana use during pregnancy and while a mother is breastfeeding.

9 Mar 2021